| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.3 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |